Let me get this straight, Prurisol was compared heavily to Otezla but somehow they ran into funding issues for 189 subjects... You really buy that garbage for why there was a 5 month gap between the lock PR and data release? They knew long before December it failed.... This trial has more subjects with less funding available... Finally, we'll know the status of IPIX in a few weeks... Sold or fold...